Computational flow cytometry as a diagnostic tool in suspected‐myelodysplastic syndromes

The diagnostic work‐up of patients suspected for myelodysplastic syndromes is challenging and mainly relies on bone marrow morphology and cytogenetics. In this study, we developed and prospectively validated a fully computational tool for flow cytometry diagnostics in suspected‐MDS. The computationa...

Full description

Saved in:
Bibliographic Details
Published inCytometry. Part A Vol. 99; no. 8; pp. 814 - 824
Main Authors Duetz, Carolien, Van Gassen, Sofie, Westers, Theresia M., Spronsen, Margot F., Bachas, Costa, Saeys, Yvan, Loosdrecht, Arjan A.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.08.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The diagnostic work‐up of patients suspected for myelodysplastic syndromes is challenging and mainly relies on bone marrow morphology and cytogenetics. In this study, we developed and prospectively validated a fully computational tool for flow cytometry diagnostics in suspected‐MDS. The computational diagnostic workflow consists of methods for pre‐processing flow cytometry data, followed by a cell population detection method (FlowSOM) and a machine learning classifier (Random Forest). Based on a six tubes FC panel, the workflow obtained a 90% sensitivity and 93% specificity in an independent validation cohort. For practical advantages (e.g., reduced processing time and costs), a second computational diagnostic workflow was trained, solely based on the best performing single tube of the training cohort. This workflow obtained 97% sensitivity and 95% specificity in the prospective validation cohort. Both workflows outperformed the conventional, expert analyzed flow cytometry scores for diagnosis with respect to accuracy, objectivity and time investment (less than 2 min per patient).
Bibliography:Funding information
Yvan Saeys and Arjan A. van de Loosdrecht contributed equally to this work.
European Union's Horizon 2020 research and innovation programme, Grant/Award Number: 634789
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Funding information European Union's Horizon 2020 research and innovation programme, Grant/Award Number: 634789
ISSN:1552-4922
1552-4930
1552-4930
DOI:10.1002/cyto.a.24360